Skip to content

Establishment of a clinical staging system for intrahepatic cholangiocarcinoma involving the hepatic hilum-a multicenter retrospective cohort study

Establishment of a clinical staging system for intrahepatic cholangiocarcinoma involving the hepatic hilum-a multicenter retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105635
Enrollment
Unknown
Registered
2025-07-08
Start date
2025-07-09
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic cholangiocarcinoma involving the hepatic hilum

Interventions

Intrahepatic cholangiocarcinoma involving the hepatic hilum:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Participants with hICC who underwent radical surgical resection. We defined hICC as intrahepatic cholangiocarcinoma ( massive type ) involving the hilar bile duct, and the center of the mass is located between the right side of the left portal vein and the left side of the right portal vein.

Exclusion criteria

Exclusion criteria: 1. Participants with hilar cholangiocarcinoma; 2. hICC participants who only underwent palliative resection ( R2 ) or hilar bile duct resection; 3. Gallbladder cancer participants with hilar bile duct involvement; 4. Papillary and periductal invasive IHC participants with hilar bile duct involvement; 5. Participants who were re-removed after the first resection in another hospital.

Design outcomes

Primary

MeasureTime frame
Prognosis ( such as overall survival, disease-free survival );Baseline information;Clinical laboratory indicators;Imaging report;Operation records;Postoperative complication;Length of hospital stay;

Countries

China

Contacts

Public ContactJiong Lu

West China Hospital, Sichuan University

lujiong@scu.edu.cn+86 189 8060 7532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026